Company/Individual
|
Product/Issue
|
Issue Date
|
|---|---|---|
manufacture of active pharmaceutical ingredients (APIs)
|
7/9/2014
| |
regulations for finished pharmaceuticals
|
7/8/2014
| |
manufacture of active pharmaceutical ingredients (APIs)
|
7/7/2014
| |
manufacture of active pharmaceutical ingredients (APIs)
|
6/16/2014
| |
manufacture of active pharmaceutical ingredients (APIs)
|
6/10/2014
| |
regulations for finished pharmaceuticals
|
5/7/2014
| |
regulations for finished pharmaceuticals
|
4/11/2014
| |
manufacture of active pharmaceutical ingredients (APIs)
|
3/18/2014
| |
manufacture of active pharmaceutical ingredients (APIs)
|
3/6/2014
| |
manufacture of active pharmaceutical ingredients (APIs)
|
2/27/2014
| |
regulations for finished pharmaceuticals
|
2/6/2014
| |
labeling/relabeling of active pharmaceutical ingredients (APIs)
|
1/31/2014
|
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, September 30, 2014
Manufacture of Active Pharmaceutical Ingredients (APIs) Who of Received Warning Letters from the FDA in 2014
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment